PP

Prosanta Paul

Active Director Director DIN 08988020
DIN 08988020 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Prosanta Paul

Data last updated:

Prosanta Paul is a Director at Astracure Lifesciences Private Limited (since 2020). The company operates in Pharma. Astracure Lifesciences Private Limited reported revenue of ₹1.06 Cr (FY 2025).

DIN 08988020
Primary Designation Director
Industry Pharma
First Appointment 08 Dec 2020
Oldest Company Age 5 yrs
Largest company Astracure Lifesciences Private Limited · ₹1.06 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Dec 20202020₹1.06 Cr (FY 2025)Active

Board colleagues of Prosanta Paul

NameDINCompanyDesignation
Tarun Kanti Dey08988019Astracure Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Astracure Lifesciences Private Limited
Premium access

Shareholding and investment profile for Prosanta Paul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prosanta Paul

Prosanta Paul currently holds 1 directorship: Astracure Lifesciences Private Limited (Director, since 08 Dec 2020, revenue ₹1.06 Cr (FY 2025)).

Prosanta Paul was first appointed on 08 Dec 2020 as Director at Astracure Lifesciences Private Limited.

The current boards of Prosanta Paul's companies include Tarun Kanti Dey (Astracure Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available